ÇÒÀιæ
Clinics- Àú³Î ´ÜÇົ
µðÁöÅÐ, ÀΰøÁö´ÉÀÇÇÐ
µ¿¹°º¸°Ç»ç
Çѱ۵µ¼­ ±âÃÊ
Çѱ۵µ¼­ ³»°ú
Çѱ۵µ¼­ ¿Ü°ú
Çѱ۵µ¼­ ¿µ»ó/¾È°ú/Ä¡°ú
Çѱ۵µ¼­ ±âŸ
±âÃÊ »ý¸íÀÇ°úÇÐ
½ÇÇ赿¹°
¼öÀÇ À±¸®/º¹Áö
±â»ýÃæ/»ê°ú/À¯Àü
°øÁߺ¸°Ç/Àü¿°º´ÇÐ
µ¶¼º/¾à¸®,¾àÀü
¸é¿ª/¹Ì»ý¹°ÇÐ
¹ß»ý/ÇغÎ/»ý¸®ÇÐ
Á¶Á÷/º´¸®ÇÐ
¼ö»ýµ¿¹°
Á¶·ù
»ê¾÷/Áß,´ëµ¿¹°
µÅÁö
¸»
¼Ò
°í¾çÀÌ
µ¿¹° º¸Á¤,Çڵ鸵
¼öÀÇ ÀϹÝ/±âŸ Âü°íµµ¼­
¼Òµ¿¹° ³»°ú
¼Òµ¿¹° ¿Ü°ú
ÀçÈ°/½Å°æ, Á¤Çü¿Ü°úÇÐ
³»½Ã°æ, ÀÚ·É/³ë·Éµ¿¹°ÇÐ
ºñ´¢±â/À̺ñÀÎÈÄ°ú
¸¶Ãë,ÅëÁõ/ÀÀ±Þ,¼ö¾×
¼ÒÈ­/¿µ¾ç/ÇǺÎÇÐ
³»ºÐºñ/½Å°æ/ÇൿÇÐ
½ÉÀå,È£Èí±â/Á¾¾çÇÐ
¾È°ú/Ä¡°úÇÐ
¿µ»óÁø´ÜÀÇÇÐ
ÀÓ»óº´¸®(¼¼Æ÷,Ç÷¾×ÇÐ)
´ëüÀÇÇÐ(ħ¼ú,Çãºê)
¾ß»ý/Ư¼öµ¿¹° Exo, Zoo
Á¾º¸Á¸/µ¿¹°º¸È£/¹ýÀÇÇÐ
º´¿ø°æ¿µ/»çÀü/¿ë¾î
BSAVA ½Ã¸®Áî
ÀÚÀ¯°áÁ¦
100ÀÚ ¼­Æò
Áú¹®°ú ´ë´ä
  T: 042-330-0039

  042-361-2500

  HP: 010-8364-0400

  F: 042-367-1017

ÆòÀÏ 10:00 ~ 18:00


À̸ÞÀϹ®ÀÇ
½ÅÇÑ 100-023-144280
±¹¹Î 732801-01-097961
³óÇù 453131-56-197831
Çϳª 660-910336-13307
¿¹±ÝÁÖ: ÀÌ»óµ· okvet
 
 
ºñ¹Ð¹øÈ£ È®ÀÎ ´Ý±â
¸é¿ª/¹Ì»ý¹°ÇÐ > ¸é¿ªÇÐ > The Design and Development of Novel Drugs and Vaccines 1st Edition - Principles and Protocols - ½Å°£POD»óÇ°

 
The Design and Development of Novel Drugs and Vaccines 1st Edition - Principles and Protocols - ½Å°£POD»óÇ°
»óÇ°¸í : The Design and Development of Novel Drugs and Vaccines 1st Edition - Principles and Protocols - ½Å°£POD»óÇ°
Á¦Á¶È¸»ç : Academic Press
Àû¸³±Ý¾× : 6,420¿ø
¼ÒºñÀÚ°¡ : 214,000¿ø
ÆǸŰ¡°Ý : 214,000¿ø
¼ö·® EA
 
¹è¼ÛÁ¶°Ç : (Á¶°Ç)
   
 

The Design and Development of Novel Drugs and Vaccines 1st Edition - Principles and Protocols - ½Å°£POD»óÇ°



½Å°£POD(Printed On Demand/ÁÖ¹®Çü¼­Àû) »óÇ° ¾È³»


ÀÌ µµ¼­´Â ½Å°£POD»óÇ°ÀÔ´Ï´Ù.

½Å°£POD: ½Å°£µµ¼­À̳ª ÃâÆÇ»çÀÇ ¹°·ùºñ Àý°¨À» À§ÇØ ÁÖ¹®½Ã¸¶´Ù Á¦ÀÛÇÏ´Â µµ¼­

            PODµµ¼­ÀÇ Æ¯¼º»ó Ã¥ÀÇ ÇüÅ·ΠÀμâÇÏ°í Á¦º»ÇÑ °á°ú¹°ÀÌ Á¤»ó Ãâ°£µÈ µµ¼­¿¡ ºñÇØ Ä÷¸®Æ¼°¡ ¶³¾îÁú ¼ö ÀÖ½À´Ï´Ù.


Editors: Tarun Kumar Bhatt Surendra Nimesh

Paperback ISBN: 9780128214718
Imprint: Academic Press                
Published Date: 22nd January 2021
Page Count: 308


Description


The Design and Development of Novel Drugs and Vaccines: Principles and Protocols presents both in silico methods and experimental protocols for vaccine and drug design and development, critically reviewing the most current research and emphasizing approaches and technologies that accelerate and lower the cost of product development. Sections review the technologies and approaches used to identify, characterize and establish a protein as a new drug and vaccine target, cover several molecular methods for in vitro studies of the desired target, and present various physiological parameters for in vivo studies. The book includes preclinical trials and research, along with information on FDA approval.



Key Features

  • Covers both in silico methods and experimental protocols for vaccine and drug development in a single, accessible volume
  • Offers a holistic accounting of how developments in bioinformatics and large experimental datasets can be used in the development of vaccines and drugs
  • Shows researchers the entire gamut of current therapies, ranging from computational inputs to animal studies
  • Reviews the most current, cutting-edge research available on vaccine and drug design and development



Readership

Researchers and advanced students in life sciences, pharmacology, chemistry, biochemistry, toxicology and pharmaceutical science



Table of Contents


1. Introduction of structural bioinformatics with respect to drug discovery
2. Target identification and validation
3. Retrieval of compounds
4. Lead identification and optimization
5. Molecular dynamics simulations
6. An overview of vaccine design
7. Key steps in the selection of vaccine targets
8. Epitope prediction and selection of linkers and adjuvant
9. Design of vaccine constructs
10. In-silico validation through protein-protein docking
11. Molecular cloning
12. Protein expression
13. Protein purification and desalting
14. Biological assay
15. Biophysical methods
16. Outline of animal study for lead/ vaccine testing
17. Evaluation of immunogenicity of vaccine candidate
18. In-vitro evaluation of lead molecule
19. Medical physiological parameter for lead/vaccine testing
20. Brief introduction of clinical research and trials
21. An overview of IND, NDA, approval agencies and FDA post-marketing surveillance
22. Introduction of Intellectual property rights



About the Editors


Tarun Kumar Bhatt

Tarun Kumar Bhatt is an Assistant Professor in the Department of Biotechnology, at the Central University of Rajasthan, India. He received his PhD from the International Centre for Genetic Engineering and Biotechnology, New Delhi and gained post-doctoral experience at the Scripps Research Institute in San Diego, California. He has published over 25 articles and has extensive experience researching drug and vaccine development.

Affiliations and Expertise

Assistant Professor, Department of Biotechnology, Central University of Rajasthan, India


Surendra Nimesh

Surendra Nimesh, UGC Assistant Professor at Central University of Rajasthan, Rajasthan, India. Surendra received his M.S. in Biomedical Science from the Dr. B.R. Ambedkar Center for Biomedical Research (ACBR), University of Delhi. He completed his PhD. In Nanotechnology at the Institute of Genomics and Integrative Biology (CSIR), Delhi. After completing his postdoctoral studies at the Ecole Polyetchnique of Montreal, Surendra joined the Clinical Research Institute of Montreal (IRCM), Canada as Postdoctoral Fellow. After completing his commitment at IRCM, he joined McGill University for short time. He also worked as NSERC visiting fellow at Health Canada, Canada. His research interests include nanoparticles-mediated gene, siRNA and drug delivery.

Affiliations and Expertise

UGC Assistant Professor, Central University of Rajasthan, Rajasthan, India             

 
 
 
 
»óÈ£¸í : OKVET »ç¾÷ÀÚµî·Ï¹øÈ£ : 314-90-93001 314-90-93001 Åë½ÅÆǸž÷½Å°í¹øÈ£ : À¯¼º±¸Ã» Á¦2006-75È£
[ÀÌ¿ë¾à°ü] [°³ÀÎÁ¤º¸ 󸮹æħ] °³ÀÎÁ¤º¸ º¸È£ Ã¥ÀÓÀÚ : ÀÌ»óµ· ´ëÇ¥ : ÀÌ»óµ·
»ç¾÷Àå¼ÒÀçÁö : ´ëÀü±¤¿ª½Ã À¯¼º±¸ Å×Å©³ë3·Î 65, ÇѽŠS-MECA 440È£
Copyright ¨Ï okvet All Rights Reserved. T: 042-330-0039, 042-361-2500, HP: 010-8364-0400, F: 042-367-1017